Fem Excel packages hormone care as an ongoing relationship, with consultations, home testing and access to a care team. The medicines are a separate part of that arrangement. A clear review therefore needs to follow both the membership and the individual prescription.

We examined Fem Excel’s current home, treatment and FAQ pages in September 2026. We have not used the service, tested its compounds or validated its advertised results. This entry explains the published model and the information needed for an informed comparison.

In this entry

Separate the starting offer from the continuing plan

The homepage advertises a $99 consultation-and-testing package alongside a $99 monthly medical membership. It also lists medicines separately and describes a first-month membership promotion. Ask which offer you are enrolling in and when the regular charges begin.

The FAQ says medicines are billed every two months. A monthly-equivalent price can therefore differ from the actual payment collected for a shipment. Request the whole first-quarter bill and the ordinary renewal bill, including every proposed medicine, before comparing it with a single monthly number elsewhere.

Keep a record of each prescribed component

Fem Excel describes a menu that can include estrogen, progesterone, testosterone and thyroid medication. Ask the prescriber to explain the purpose of every item. A broad menu is a set of possible options, not evidence that a more extensive regimen is appropriate for your symptoms.

Use the prescription guide to record the formulation, route and instructions. Add the dispensing pharmacy and contact details. If several medicines arrive together, you should still be able to identify each one and explain what it is intended to do.

Ask about the finished medicine’s approval status

The FAQ identifies Fem Excel’s hormones as compounded. These finished preparations do not have FDA approval. A description of a registered pharmacy, a testing laboratory or the source of an ingredient answers a different question from whether the drug has been approved.

Our approved-versus-compounded guide explains why that distinction matters. Ask what particular need the formulation meets and what approved options were considered. Do not assume that bioidentical means compounded, or that a custom preparation is necessarily better tolerated because it is presented as natural.

Make the safety discussion specific

If systemic estrogen is recommended, the presence of a uterus affects the discussion about progestogen. Ask what evidence supports that part of the exact regimen, rather than rely on progesterone appearing somewhere in a product list. Our progesterone medicine guide supplies the background.

Testosterone has a separate evidence and side-effect discussion. Medical monitoring cannot guarantee the absence of unwanted effects such as hair growth or voice changes. Review testosterone in women and ask how benefit, unwanted changes and the need to continue will be assessed. Thyroid treatment also needs its own clinical rationale.

Understand how testing changes decisions

The FAQ describes testing during membership and notes that a clinician may sometimes begin treatment before results return. Ask what supports that initial decision and what the subsequent test is meant to clarify. A record of symptoms and current medicines is important alongside any laboratory result.

Find out who reviews unexpected findings and whether further evaluation can create additional charges. If you already have recent test results, ask how they fit into enrollment. You should understand what happens at the first review, not only how to send a sample back.

Check the financial promises carefully

Fem Excel says it does not accept insurance. Ask your own benefit administrator about eligibility before relying on an HSA, FSA or reimbursement reference. The published membership guarantee also has conditions; ask which fees it covers and how a request would be assessed.

Keep those financial terms separate from a medical expectation. A refund offer does not establish that treatment is risk-free or that it will help every patient. The care-plan budgeting guide explains how to show a potential refund separately from money you must pay upfront.

Compare the same scope of care

Joi and Thrivelab give other recurring-care examples. Pandia Health provides a comparison centered on approved menopause medicine options. Use actual prescriptions and likely follow-up needs to make those comparisons meaningful.

Fem Excel’s program can be evaluated only after its separate charges and treatment rationale are clear. If you already receive HRT, follow the care-transfer checklist so the old and new services agree on responsibilities. Opening an account does not itself transfer prescribing or refill obligations.

CHECK THE ORIGINAL

The source record

Provider pages document their own offers. Medical and regulatory sources provide treatment context. This is not a record of personal patient testing. All sources checked September 20, 2026.

  1. Fem Excel: current consultation, membership and medicine prices
  2. Fem Excel: compounding, billing and transfer FAQ
  3. Fem Excel: hormone treatment options
  4. FDA: understanding the risks of compounded drugs
  5. ACOG: compounded bioidentical menopausal hormone therapy, reaffirmed 2026
  6. The Menopause Society: hormone therapy
This entry is educational. Decisions about a prescription belong with a licensed clinician who can assess your history. If you have a medical emergency, call 911.